Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 17.88M $1.11B June 30, 2014
FMR 12.58M $907.83M Sept. 30, 2014
Sands Capital Management 12.10M $873.04M Sept. 30, 2014
Vanguard 8.49M $612.80M Sept. 30, 2014
PRIMECAP Management Company 8.04M $580.45M Sept. 30, 2014
Jennison Associates 5.97M $430.50M Sept. 30, 2014
WINSLOW CAPITAL MANAGEMENT INC /MN 4.82M $328.84M March 31, 2014
STATE STREET CORPORATION 3.96M $285.63M Sept. 30, 2014
Capital World Investors^ 3.68M $205.21M June 30, 2013
Altrinsic Global Advisors 3.59M $144.55M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 3.52M $253.88M Sept. 30, 2014
Inves 3.19M $128.31M Sept. 30, 2012
Columbia Wanger Asset Management 3.10M $193.32M March 31, 2013
Manning & Napier Advisors 3.04M $96.76M Sept. 30, 2011
BlackRock Fund Advisors 2.95M $212.65M Sept. 30, 2014
BNP PARIBAS ARBITRAGE, SNC 2.94M $302.99M March 31, 2014
Wells Fargo & Company 2.92M $181.68M June 30, 2014
T. Rowe Price Associates 2.84M $205.41M Sept. 30, 2013

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Cramer Rosenthal McGlynn Sept. 30, 2011 3.92M $125.08M
Sectoral Asset Management Sept. 30, 2011 3.54M $112.96M
Munder Capital Management Sept. 30, 2011 2.98M $94.96M
OrbiMed Advisors Dec. 31, 2010 3.41M $91.82M